Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy

Immune escape is a frequent occurrence, which limits the duration of antitumor immune responses to radiotherapy. Here, we aimed to ascertain the roles and underlying mechanisms of programmed death ligand 1 (PD-L1) in tolerance of breast cancer (BC) to radiotherapy. We first quantified microRNA-21 (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lei-Ming, Ding, Gao-Feng, Xu, Wen-Cai, Ge, Hong, Jiang, Yue, Lu, Yu-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920704/
https://www.ncbi.nlm.nih.gov/pubmed/35295718
http://dx.doi.org/10.1155/2022/5938688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920704/
https://www.ncbi.nlm.nih.gov/pubmed/35295718
http://dx.doi.org/10.1155/2022/5938688

Ejemplares similares